Propel Bio Management, LLC
- SEC CIK
- 0001969764
- Latest filing
- Aug 13, 2026
Holdings in Q4 2023
Holdings as of Dec 31, 2023, filed Feb 14, 2024. Long positions only.
- Positions
- 34
- No filing for Q3 2023
- Portfolio value
- $120.6M
- No filing for Q3 2023
Propel Bio Management, LLC did not file a 13F for Q3 2023, so these holdings cannot be compared with the previous quarter and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PAGPPlains GP Holdings LP | LTD PARTNR INT A | 1,372,360 | $21.9M | 18.1% | – | – | History |
| APLTApplied Therapeutics, Inc. | COM | 5,374,982 | $18.0M | 14.9% | – | – | History |
| TCRXTScan Therapeutics, Inc. | COM | 2,087,139 | $12.2M | 10.1% | – | – | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 30,032 | $6.95M | 5.8% | – | – | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 165,000 | $5.87M | 4.9% | – | – | History |
| FULCFulcrum Therapeutics, Inc. | COM | 750,000 | $5.06M | 4.2% | – | – | History |
| Fidelity Inv Mmtrsy 1 680X9USDFIDT | COMM | 4,772,389 | $4.77M | 4.0% | – | – | – |
| PHATPhathom Pharmaceuticals, Inc. | COM | 443,047 | $4.05M | 3.4% | – | – | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 270,664 | $3.95M | 3.3% | – | – | History |
| ARDXArdelyx, Inc. | COM | 594,174 | $3.68M | 3.1% | – | – | History |
| LONALeonaBio, Inc. | COM | 1,492,792 | $3.63M | 3.0% | – | – | History |
| TSATTelesat Corp | CL A & CL B SHS | 290,781 | $3.03M | 2.5% | – | – | History |
| Simplify Exchange Traded Fun82889N632 | ENHANCED INM ETF | 120,221 | $2.95M | 2.4% | – | – | – |
| AKROAkero Therapeutics, Inc. | COM | 100,052 | $2.34M | 1.9% | – | – | History |
| Vanguard Short-Term Bond ETF921937827 | ETF | 27,712 | $2.13M | 1.8% | – | – | – |
| iShares Tr46434VBG4 | IBONDS DEC24 ETF | 85,442 | $2.13M | 1.8% | – | – | – |
| iShares Tr464288588 | MBS ETF | 22,400 | $2.11M | 1.7% | – | – | – |
| MIRMMirum Pharmaceuticals, Inc. | COM | 70,000 | $2.07M | 1.7% | – | – | History |
| MRNSMarinus Pharmaceuticals, Inc. | COM NEW | 180,100 | $1.96M | 1.6% | – | – | History |
| KURAKura Oncology, Inc. | COM | 130,000 | $1.87M | 1.5% | – | – | History |
| Avidity Biosciences, Inc.05370A108 | COM | 178,500 | $1.62M | 1.3% | – | – | – |
| KYMRKymera Therapeutics, Inc. | COM | 56,359 | $1.43M | 1.2% | – | – | History |
| State Street SPDR Portfolio Short Term Corporate Bond ETF78464A474 | ETF | 45,695 | $1.36M | 1.1% | – | – | – |
| KYNKayne Anderson Energy Infrastructure Fund, Inc. | COM | 147,033 | $1.29M | 1.1% | – | – | History |
| EIGREiger BioPharmaceuticals, Inc. | COM | 4,391,432 | $985.9K | 0.8% | – | – | History |
| STROSutro Biopharma, Inc. | COM | 195,000 | $836.5K | 0.7% | – | – | History |
| iShares Tr46434V100 | 0-5YR INVT GR CP | 12,148 | $597.7K | 0.5% | – | – | – |
| iShares Iboxx $ Investment Grade Corporate Bond ETF464287242 | ETF | 4,456 | $493.1K | 0.4% | – | – | – |
| XFORX4 Pharmaceuticals, Inc | COM | 535,000 | $448.6K | 0.4% | – | – | History |
| Cybin Ord23256X100 | COM | 850,000 | $348.5K | 0.3% | – | – | – |
| SPDR Series Trust78468R200 | ST STR RATE ETF | 9,267 | $283.5K | 0.2% | – | – | – |
| HRTXHeron Therapeutics, Inc. | COM | 104,195 | $177.1K | 0.1% | – | – | History |
| AGIOAgios Pharmaceuticals, Inc. | COM | 5,792 | $129.0K | 0.1% | – | – | History |
| Contra Chinook Therapeu169CVR016 | COM | 79,357 | $0 | 0.0% | – | – | – |